knowledge -WSS

knowledge

author：leisure time 2025-09-27 12:47:32 - browse：32231

Hevolution's executive team includes, from left, Sophia Pathai, Haya Bint Khaled Bin Bandar Al Saud, Mehmood Khan, and Salman AlAsiry. Courtesy Hashem Al-Sh

The Hevolution Foundation, a Saudi investment firm focused on aging science, said Wednesday that it is launching an incubator that will bring together experts from the scientific community, pharma, and multiple biotech VCs.

The incubator, called the Breakthrough Innovation Alliance, will give up to $1 million apiece to 10 different research initiatives over the next three years, allowing scientists and entrepreneurs to run preclinical research to determine whether the ideas hold any promise. The projects will be evaluated by a committee made up of representatives from Hevolution, Novo Nordisk, 5AM Ventures, RA Capital, and drug company EvoTec. The best projects will become the basis of new startups, co-funded by Hevolution.

It’s all part of Hevolution’s plan to funnel up to $1 billion each year into academic research and biotech startups that are focused on aging-related diseases and and helping people live healthier lives longer, or what is sometimes referred to as “healthspan.” As part of that effort, the firm also announced at a conference in the Saudi capital of Riyadh this week that it will give around $80 million to a handful of research initiatives, including $21 million to establish a partnership with the Buck Institute for Research on Aging.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： Pfizer plans to depart BIO

explore

WSS

AI models in health care face new federal disclosure requirements

How digital therapeutics firms are pivoting after Pear's bankruptcy

Leukemia patients are helped by Syndax's new type of therapy

CMS should re

The surgeon had a dilemma only a Nazi medical text could resolve

Teach medical students about patients with intellectual disabilities

focus

knowledge

Wikipedia

Cancer drug shortages should be causing more outrage

How digital therapeutics firms are pivoting after Pear's bankruptcy

In age of alternative facts, a scholarly course on calling out crap

Elizabeth Holmes banned from government health programs

The high cost of giving birth even with insurance

The woman behind the Dana Farber

Novavax promises a turnaround & Lilly roils the obesity market

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Cancer drug shortages should be causing more outrage

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

leisure time

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Spinal cord stimulation reduces pain in amputees, study finds

Test for long Covid? Researchers find new clue in blood samples

Parkinson’s finding may lead to tests and, someday, treatments

FDA clears AI tool for detecting skin cancer

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

leisure time

entertainment

explore

hotspot